Buprenorphine versus methadone for opioid use disorder in pregnancy

E. A. SUAREZ ; K. F. HUYBRECHTS ; L. STRAUB ; S. HERNANDEZ-DIAZ ; H. E. JONES ; H. S. CONNERY ; J. M. DAVIS ; K. J. GRAY ; B. LESTER ; M. TERPLAN ; H. MOGUN ; B. T. BATEMAN | 2022
Dans New England Journal of Medicine (Vol.387, n°22, December 1, 2022) Article : Périodique

Background: Opioid agonist therapy is strongly recommended for pregnant persons with opioid use disorder. Buprenorphine may be associated with more favorable neonatal and maternal outcomes than methadone, but existing data are limited. Methods:[...]

Plus d'info

Ajouter à la sélection

Lien externe

Treatment of patients with substance use disorders, second edition

American Psychiatric Association ; Work group on substance use disorders ; Steering committee on practice guidelines ; H. D. KLEBER ; R. D. WEISS ; R. F. ANTON ; T. P. GEORGE ; S. F. GREENFIELD ; T. R. KOSTEN ; C. P. O'BRIEN ; B. J. ROUNSAVILLE ; E. C. STRAIN ; ZIEDONIS D. M. ; HENNESSY G. ; H. S. CONNERY ; J. S. McINTYRE ; S. C. CHARLES ; D. J. ANZIA ; I. A. COOK ; M. T. FINNERTY ; B. R. JOHNSON ; NININGER J. E. ; P. SUMMERGRAD ; S. M. WOODS ; YAGER J. ; PYLES R. ; C. D. CROSS ; R. PEELE ; SHEMO J. P. ; L. LURIE ; R. D. WALKER ; M. A. BARNOVITZ ; S. H. GRAY ; S. SAXENA ; TONNU T. ; KUNKLE R. ; A. B. ALBERT ; FOCHTMANN L. J. ; C. HART ; D. REGIER | 2007
Dans American Journal of Psychiatry (Vol.164, n°4 Suppl., 2007) Article : Périodique

Individuals with substance use disorders are heterogeneous with regard to a number of clinically important features and domains of functioning. Consequently, a multimodal approach to treatment is typically required. Care of individuals with subs[...]

Plus d'info

Ajouter à la sélection

Lien externe